Cancer Organoids in Basic Science and Translational Medicine

Lorenzo Memeo¹, Vincenzo Canzonieri^{2

3}, Flavio Rizzolio^{2

4}

Affiliations

¹ Department of Experimental Oncology, Mediterranean Institute of Oncology, 95029 Catania, Italy.
² Department of Pathology, IRCCS CRO Aviano National Cancer Institute, 33081 Aviano, Italy.
³ Department of Medical Surgical and Health Sciences, University of Trieste, 34127 Trieste, Italy.
⁴ Department of Molecular Science and Nanosystems, Università Ca' Foscari Venezia, 30170 Venice, Italy.

Editorial

Lorenzo Memeo et al. Cancers (Basel). 2021.

. 2021 Jul 23;13(15):3701.

doi: 10.3390/cancers13153701.

Lorenzo Memeo¹, Vincenzo Canzonieri^{2

3}, Flavio Rizzolio^{2

4}

¹ Department of Experimental Oncology, Mediterranean Institute of Oncology, 95029 Catania, Italy.
² Department of Pathology, IRCCS CRO Aviano National Cancer Institute, 33081 Aviano, Italy.
³ Department of Medical Surgical and Health Sciences, University of Trieste, 34127 Trieste, Italy.
⁴ Department of Molecular Science and Nanosystems, Università Ca' Foscari Venezia, 30170 Venice, Italy.

Abstract

Organoids are revolutionizing approaches to cancer therapy and even diagnosis [...].

The authors declare no conflict of interest.

1. Papazoglou E.D., Jagirdar R.M., Kouliou O.A., Pitaraki E., Hatzoglou C., Gourgoulianis K.I., Zarogiannis S.G. In vitro characterization of cisplatin and pemetrexed effects in malignant pleural mesothelioma 3d culture phenotypes. Cancers. 2019;11:1446. doi: 10.3390/cancers11101446. - DOI - PMC - PubMed
1. Sensi F., D’angelo E., Piccoli M., Pavan P., Mastrotto F., Caliceti P., Biccari A., Corallo D., Urbani L., Fassan M., et al. Recellularized colorectal cancer patient-derived scaffolds as in vitro pre-clinical 3D model for drug screening. Cancers. 2020;12:681. doi: 10.3390/cancers12030681. - DOI - PMC - PubMed
1. Hum N.R., Sebastian A., Gilmore S.F., He W., Martin K.A., Hinckley A., Dubbin K.R., Moya M.L., Wheeler E.K., Coleman M.A., et al. Comparative molecular analysis of cancer behavior cultured in vitro, in vivo, and ex vivo. Cancers. 2020;12:690. doi: 10.3390/cancers12030690. - DOI - PMC - PubMed
1. Sondorp L.H.J., Ogundipe V.M.L., Groen A.H., Kelder W., Kemper A., Links T.P., Coppes R.P., Kruijff S. Patient-derived papillary thyroid cancer organoids for radioactive iodine refractory screening. Cancers. 2020;12:3212. doi: 10.3390/cancers12113212. - DOI - PMC - PubMed
1. Campaner E., Zannini A., Santorsola M., Bonazza D., Bottin C., Cancila V., Tripodo C., Bortul M., Zanconati F., Schoeftner S., et al. Breast cancer organoids model patient-specific response to drug treatment. Cancers. 2020;12:3869. doi: 10.3390/cancers12123869. - DOI - PMC - PubMed